Search Results - "Schaik, I. N."

Refine Results
  1. 1
  2. 2

    Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment by EFTIMOV, F, VERMEULEN, M, VAN DOORN, P. A, BRUSSE, E, VAN SCHAIK, I. N

    Published in Neurology (03-04-2012)
    “…Achieving long-term remission after a limited more intense treatment period would prevent prolonged use of corticosteroids or IV immunoglobulin (IVIg) in…”
    Get full text
    Journal Article
  3. 3

    Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value by Zoons, E., Dijkgraaf, M. G. W., Dijk, J. M., van Schaik, I. N., Tijssen, M. A.

    Published in Journal of neurology (01-12-2012)
    “…Focal dystonia is a common, invalidating neurologic condition characterized by involuntary, sustained muscle contractions causing twisting movements and…”
    Get full text
    Journal Article
  4. 4

    Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot study by Adrichem, M. E., Bus, S. R., Wieske, L., Mohammed, H., Verhamme, C., Hadden, R., Schaik, I. N., Eftimov, F.

    Published in European journal of neurology (01-03-2020)
    “…Background and purpose We hypothesized that combining intravenous immunoglobulin (IVIg) and intravenous methylprednisolone (IVMP) leads to more frequent…”
    Get full text
    Journal Article
  5. 5

    Somatosensory evoked potentials during mild hypothermia after cardiopulmonary resuscitation by BOUWES, A, BINNEKADE, J. M, ZANDSTRA, D. F, KOELMAN, J. H. T. M, VAN SCHAIK, I. N, HIJDRA, A, HORN, J

    Published in Neurology (03-11-2009)
    “…In patients who remain in a coma after cardiopulmonary resuscitation (CPR), the bilateral absence of cortical N20 responses of median nerve somatosensory…”
    Get full text
    Journal Article
  6. 6

    Clinical outcome of CIDP one year after start of treatment: a prospective cohort study by Bus, S. R. M., Broers, M. C., Lucke, I. M., Bunschoten, C., van Lieverloo, G. G. A., Adrichem, M. E., van Veen, R., Wieske, L., Lingsma, H. F., Goedee, H. S., van der Pol, W. L., van Schaik, I. N., Van Doorn, P. A., Jacobs, B. C., Eftimov, F.

    Published in Journal of neurology (01-02-2022)
    “…Objective To assess clinical outcome in treatment-naive patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Methods We included…”
    Get full text
    Journal Article
  7. 7

    The effect of tremor on disability assessment in chronic inflammatory demyelinating polyradiculoneuropathy by Veen, R., Pallada, G., Wieske, L., Ten Holter, S. E. M., Rootselaar, A. F., Verhamme, C., Bie, R. M. A., Schaik, I. N., Merkies, I. S. J., Dijk, J. M., Eftimov, Filip

    Published in Journal of the peripheral nervous system (01-03-2023)
    “…Tremor in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is common, often unresponsive to treatment, and may contribute to disability. We aim…”
    Get full text
    Journal Article
  8. 8

    B‐cell and T‐cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study by Lieverloo, G. G. A., Al‐Soudi, A., Wieske, L., Klarenbeek, P. L., Anang, D. C., Adrichem, M. E., Niewold, I., Schaik, B. D. C., Kampen, A. H. C., Schaik, I. N., Vries, N., Eftimov, F.

    Published in Journal of the peripheral nervous system (01-03-2023)
    “…The immunopathophysiological mechanisms underlying chronic inflammatory demyelinating polyneuropathy (CIDP) in an individual patient are largely unknown…”
    Get full text
    Journal Article
  9. 9
  10. 10

    ‘Non-neuronopathic’ Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature by Biegstraaten, M., van Schaik, I. N., Aerts, J. M. F. G., Hollak, C. E. M.

    Published in Journal of inherited metabolic disease (01-06-2008)
    “…Summary Gaucher disease is a lysosomal storage disorder, which is classically divided into three types. Type I Gaucher disease is differentiated from types II…”
    Get full text
    Journal Article
  11. 11

    Pain management strategies for neuropathic pain in Fabry disease--a systematic review by Schuller, Y, Linthorst, G E, Hollak, C E M, Van Schaik, I N, Biegstraaten, M

    Published in BMC neurology (24-02-2016)
    “…Neuropathic pain is one of the key features of (classical) Fabry disease (FD). No randomized clinical trials comparing effectiveness of different pain…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Autonomic dysfunction in ICU-acquired weakness: a prospective observational pilot study by Wieske, L., Chan Pin Yin, D. R. P. P., Verhamme, C., Schultz, M. J., van Schaik, I. N., Horn, J.

    Published in Intensive care medicine (01-09-2013)
    “…Purpose Intensive care unit-acquired weakness (ICU-AW) is a frequent complication of critical illness. It is unknown if patients with ICU-AW also have…”
    Get full text
    Journal Article
  15. 15

    Examination of cardiovascular and peripheral autonomic function in the ICU: a pilot study by Wieske, L., Kiszer, E. R., Schultz, M. J., Verhamme, C., van Schaik, I. N., Horn, J.

    Published in Journal of neurology (01-06-2013)
    “…Critical illness may affect the autonomic nervous system. Decreased cardiovascular autonomic function measured by heart rate variability (HRV) has been…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Intravenous immunoglobulin for multifocal motor neuropathy by van Schaik, I N, van den Berg, L H, de Haan, R, Vermeulen, M

    Published in Cochrane database of systematic reviews (18-04-2005)
    “…Multifocal motor neuropathy is a rare, probably immune mediated disorder characterised by slowly progressive, asymmetric, distal weakness of one or more limbs…”
    Get more information
    Journal Article
  18. 18

    EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases by Elovaara, I., Apostolski, S., Van Doorn, P., Gilhus, N. E., Hietaharju, A., Honkaniemi, J., Van Schaik, I. N., Scolding, N., Soelberg Sørensen, P., Udd, B.

    Published in European journal of neurology (01-09-2008)
    “…Despite high‐dose intravenous immunoglobulin (IVIG) is widely used in treatment of a number of immune‐mediated neurological diseases, the consensus on its…”
    Get full text
    Journal Article
  19. 19

    Ethnicity a risk factor? The relation between ethnicity and large- and small-vessel disease in White people, Black people, and Asians within a hospital-based population by Wolma, J., Nederkoorn, P. J., Goossens, A., Vergouwen, M. D. I., Van Schaik, I. N., Vermeulen, M.

    Published in European journal of neurology (01-04-2009)
    “…Background:  Previous studies suggest that in patients with ischaemic stroke, White people often present with large‐vessel and Black people with small‐vessel…”
    Get full text
    Journal Article
  20. 20